Balance Sheet Divi's Laboratories Limited

Equities

DIVISLAB

INE361B01024

Pharmaceuticals

Delayed NSE India S.E. Other stock markets 02:52:55 10/03/2026 pm IST			5-day change	1st Jan Change
6,387.00 ^INR	+0.90%		+1.09%	-0.12%

12/02	Jefferies Adjusts Divi's Laboratories' Price Target to INR8,100 From INR8,000, Keeps at Buy	MT
11/02	Divi's Laboratories Limited, Q3 2026 Earnings Call, Feb 11, 2026

c843a60487ebf90.Tjgq3HeJmGQxOfT3BCsXPHOeR9dJo3ziKJ9OTGXWSeY.eAFpjyXhwT5uf4G6bnk6bRamN7Uu5UiIQeoLfiegEIEde1qdJ8CvE1MNxA

Published financial data: DIVI'S LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	6.97TCr	8.96TCr	7.77TCr	7.84TCr	9.36TCr
Other Revenues, Total	7L	9L	10L	-	-
Total Revenues	6.97TCr	8.96TCr	7.77TCr	7.84TCr	9.36TCr
Cost of Goods Sold, Total	2.48TCr	3.17TCr	3.28TCr	3.35TCr	3.72TCr
Gross Profit	4.49TCr	5.79TCr	4.49TCr	4.49TCr	5.64TCr
Selling General & Admin Expenses, Total	836.69Cr	957.09Cr	987.04Cr	1.11TCr	1.26TCr
Provision for Bad Debts	-	-	-	-	-
R&D Expenses	-	-	-	-	-
Depreciation & Amortization - (IS)	255.59Cr	311.51Cr	343.18Cr	378Cr	402Cr
Other Operating Expenses	785.33Cr	952.58Cr	1.13TCr	1.18TCr	1.4TCr
Other Operating Expenses, Total	1.88TCr	2.22TCr	2.46TCr	2.66TCr	3.06TCr
Operating Income	2.61TCr	3.57TCr	2.03TCr	1.83TCr	2.57TCr
Interest Expense, Total	-39L	-37L	-33L	-3Cr	-2Cr
Interest And Investment Income	57Cr	69Cr	204.59Cr	301Cr	295Cr
Net Interest Expenses	57Cr	69Cr	204.26Cr	298Cr	293Cr
Currency Exchange Gains (Loss)	-4.38Cr	41Cr	129.67Cr	30Cr	48Cr
Other Non Operating Income (Expenses)	2.12Cr	3.81Cr	9.96Cr	3Cr	4Cr
EBT, Excl. Unusual Items	2.67TCr	3.69TCr	2.37TCr	2.16TCr	2.92TCr
Gain (Loss) On Sale Of Investments	2.65Cr	-	-	5Cr	5Cr
Gain (Loss) On Sale Of Assets	-5.96Cr	-2.05Cr	-1.13Cr	-4Cr	-4Cr
Asset Writedown	-	-	-	-	-
Insurance Settlements	-	-	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	2.67TCr	3.68TCr	2.37TCr	2.16TCr	2.92TCr
Income Tax Expense	681.75Cr	723.05Cr	545.25Cr	563Cr	725Cr
Earnings From Continuing Operations	1.98TCr	2.96TCr	1.82TCr	1.6TCr	2.19TCr
Net Income to Company	1.98TCr	2.96TCr	1.82TCr	1.6TCr	2.19TCr
Net Income - (IS)	1.98TCr	2.96TCr	1.82TCr	1.6TCr	2.19TCr
Net Income to Common Incl Extra Items	1.98TCr	2.96TCr	1.82TCr	1.6TCr	2.19TCr
Net Income to Common Excl. Extra Items	1.98TCr	2.96TCr	1.82TCr	1.6TCr	2.19TCr
Per Share Items
Net EPS - Basic	74.75	111.52	68.69	60.27	82.53
Basic EPS - Continuing Operations	74.75	111.52	68.69	60.27	82.53
Basic Weighted Average Shares Outstanding	27Cr	27Cr	27Cr	27Cr	27Cr
Net EPS - Diluted	74.75	111.52	68.69	60.27	82.53
Diluted EPS - Continuing Operations	74.75	111.52	68.69	60.27	82.53
Diluted Weighted Average Shares Outstanding	27Cr	27Cr	27Cr	27Cr	27Cr
Normalized Basic EPS	62.85	86.77	55.79	50.9	68.63
Normalized Diluted EPS	62.85	86.77	55.79	50.9	68.63
Dividend Per Share	20	30	30	30	30
Payout Ratio	-	17.93	43.68	49.75	36.33
Supplemental Items
EBITDA	2.87TCr	3.88TCr	2.36TCr	2.2TCr	2.97TCr
EBITA	2.61TCr	3.57TCr	2.03TCr	1.83TCr	2.57TCr
EBIT	2.61TCr	3.57TCr	2.03TCr	1.83TCr	2.57TCr
EBITDAR	2.88TCr	3.89TCr	2.38TCr	2.22TCr	2.98TCr
Total Revenues (As Reported)	7.03TCr	9.07TCr	8.11TCr	8.18TCr	9.71TCr
Effective Tax Rate - (Ratio)	25.57	19.63	23.02	26.03	24.86
Total Current Taxes	616.46Cr	644Cr	439.17Cr	514Cr	799Cr
Total Deferred Taxes	65Cr	79Cr	106.08Cr	49Cr	-74Cr
Normalized Net Income	1.67TCr	2.3TCr	1.48TCr	1.35TCr	1.82TCr
Interest on Long-Term Debt	18L	15L	15L	-	-
Non-Cash Pension Expense	-14L	-18L	11L	0	0
Supplemental Operating Expense Items
Advertising Expense	7L	16L	15L	-	-
Selling and Marketing Expenses	7L	16L	15L	-	-
Research And Development Expense From Footnotes	51Cr	55Cr	69Cr	79Cr	80Cr
Net Rental Expense, Total	11Cr	11Cr	12Cr	12Cr	15Cr
Imputed Operating Lease Interest Expense	1.55Cr	7.48Cr	9.02Cr	82Cr	69Cr
Imputed Operating Lease Depreciation	9.31Cr	3.29Cr	2.85Cr	-70Cr	-54Cr
Maintenance & Repair Expenses, Total	153.02Cr	199.03Cr	223.48Cr	223Cr	7Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	2.03TCr	1.21TCr	169.7Cr	363Cr	415Cr
Short Term Investments	55Cr	1.53TCr	3.96TCr	3.34TCr	3.11TCr
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	2.08TCr	2.74TCr	4.13TCr	3.7TCr	3.53TCr
Accounts Receivable, Total	1.68TCr	2.42TCr	1.79TCr	2.16TCr	2.73TCr
Other Receivables	101.78Cr	104.46Cr	141.14Cr	205Cr	247Cr
Notes Receivable	-	-	-	-	-
Total Receivables	1.78TCr	2.53TCr	1.93TCr	2.36TCr	2.98TCr
Inventory	2.15TCr	2.83TCr	3TCr	3.18TCr	3.24TCr
Prepaid Expenses	22Cr	27Cr	27Cr	36Cr	37Cr
Other Current Assets, Total	143.72Cr	225.79Cr	218.1Cr	396Cr	303Cr
Total Current Assets	6.17TCr	8.35TCr	9.31TCr	9.68TCr	10TCr
Gross Property Plant And Equipment	5.38TCr	6.07TCr	6.55TCr	7.51TCr	8.86TCr
Accumulated Depreciation	-973.47Cr	-1.28TCr	-1.62TCr	-1.99TCr	-2.4TCr
Net Property Plant And Equipment	4.41TCr	4.79TCr	4.93TCr	5.51TCr	6.46TCr
Long-term Investments	1L	72Cr	77Cr	82Cr	65Cr
Other Intangibles, Total	4.95Cr	7.49Cr	5.28Cr	4Cr	4Cr
Accounts Receivable Long-Term	-	-	-	-	-
Loans Receivable Long-Term	55Cr	-	-	-	-
Deferred Tax Assets Long-Term	3.23Cr	14Cr	14Cr	10Cr	11Cr
Other Long-Term Assets, Total	126.3Cr	141.75Cr	101.26Cr	186Cr	311Cr
Total Assets	11TCr	13TCr	14TCr	15TCr	17TCr
Liabilities
Accounts Payable, Total	763.2Cr	795.7Cr	762.51Cr	824Cr	910Cr
Accrued Expenses, Total	248.57Cr	323.46Cr	255.77Cr	244Cr	346Cr
Short-term Borrowings	35L	-	-	-	2Cr
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	79L	82L	49L	1Cr	-
Current Income Taxes Payable	5.98Cr	1.68Cr	2.21Cr	43Cr	-
Unearned Revenue Current, Total	64L	76L	87L	1Cr	1Cr
Other Current Liabilities	93Cr	73Cr	79Cr	165Cr	193Cr
Total Current Liabilities	1.11TCr	1.2TCr	1.1TCr	1.28TCr	1.45TCr
Long-Term Debt	-	-	-	-	-
Long-Term Leases	3.69Cr	2.87Cr	2.77Cr	2Cr	2Cr
Pension & Other Post Retirement Benefits	-	-	-	-	-
Deferred Tax Liability Non Current	338.06Cr	421.4Cr	537.21Cr	582Cr	509Cr
Other Non Current Liabilities	25Cr	27Cr	31Cr	37Cr	-
Total Liabilities	1.48TCr	1.65TCr	1.67TCr	1.9TCr	1.96TCr
Common Stock, Total	53Cr	53Cr	53Cr	53Cr	53Cr
Additional Paid In Capital	80Cr	80Cr	80Cr	80Cr	80Cr
Retained Earnings	9.15TCr	12TCr	13TCr	13TCr	15TCr
Comprehensive Income and Other	14Cr	16Cr	25Cr	26Cr	31Cr
Total Common Equity	9.29TCr	12TCr	13TCr	14TCr	15TCr
Total Equity	9.29TCr	12TCr	13TCr	14TCr	15TCr
Total Liabilities And Equity	11TCr	13TCr	14TCr	15TCr	17TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	27Cr	27Cr	27Cr	27Cr	27Cr
ECS Total Common Shares Outstanding	27Cr	27Cr	27Cr	27Cr	27Cr
Book Value / Share	350.12	441.79	480.93	511.21	563.87
Tangible Book Value	9.29TCr	12TCr	13TCr	14TCr	15TCr
Tangible Book Value Per Share	349.93	441.51	480.73	511.06	563.72
Total Debt	4.83Cr	3.69Cr	3.26Cr	3Cr	4Cr
Net Debt	-2.08TCr	-2.74TCr	-4.13TCr	-3.7TCr	-3.52TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	-93L	-2.37Cr	-78L	-10Cr	1Cr
Debt Equivalent Oper. Leases	87Cr	86Cr	95Cr	96Cr	120Cr
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	705.51Cr	782.18Cr	981.05Cr	1.1TCr	1.05TCr
Inventories - Work In Process, Total	1.09TCr	1.53TCr	1.53TCr	1.62TCr	1.7TCr
Inventories - Finished Goods, Total	233.57Cr	319.15Cr	302Cr	317Cr	335Cr
Inventories - Others	112.81Cr	195.7Cr	191.65Cr	148Cr	157Cr
Land - (BS)	171.51Cr	172.74Cr	194.23Cr	195Cr	202Cr
Buildings, Total	-	-	-	-	-
Machinery, Total	3.35TCr	3.99TCr	4.58TCr	4.86TCr	5.5TCr
Full Time Employees	16.82T	16.54T	8.43T	9.74T	10.54T
Accumulated Allowance for Doubtful Accounts (Supple)	5.55Cr	5.12Cr	5.87Cr	10Cr	7Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	1.98TCr	2.96TCr	1.82TCr	1.6TCr	2.19TCr
Depreciation & Amortization - CF	252.62Cr	308.33Cr	339.26Cr	375Cr	399Cr
Depreciation & Amortization, Total	252.62Cr	308.33Cr	339.26Cr	375Cr	399Cr
Amortization of Deferred Charges, Total - (CF)	2.97Cr	3.18Cr	3.92Cr	3Cr	3Cr
(Gain) Loss From Sale Of Asset	5.96Cr	2.05Cr	1.13Cr	4Cr	4Cr
(Gain) Loss on Sale of Investments - (CF)	-2.65Cr	-	-5.04Cr	-5Cr	-4Cr
Asset Writedown & Restructuring Costs	-	-	-	-	-
Provision and Write-off of Bad Debts	-11L	-2.03Cr	33L	4Cr	-2Cr
Other Operating Activities, Total	-32Cr	10Cr	-122.06Cr	-113Cr	-384Cr
Change In Accounts Receivable	-265.4Cr	-741.62Cr	650.41Cr	-361Cr	-582Cr
Change In Inventories	-281.37Cr	-683.39Cr	-171.79Cr	-184Cr	-52Cr
Change In Accounts Payable	174.8Cr	34Cr	-34Cr	62Cr	95Cr
Change in Other Net Operating Assets	107.89Cr	20Cr	-26Cr	-124Cr	-15Cr
Cash from Operations	1.95TCr	1.91TCr	2.46TCr	1.26TCr	1.65TCr
Capital Expenditure	-910.19Cr	-713.2Cr	-473.02Cr	-1TCr	-1.44TCr
Sale of Property, Plant, and Equipment	15L	-	1L	-	-
Investment in Marketable and Equity Securities, Total	928.16Cr	-1.55TCr	-2.44TCr	434Cr	339Cr
Other Investing Activities, Total	57Cr	67Cr	204.59Cr	300Cr	295Cr
Cash from Investing	75Cr	-2.19TCr	-2.71TCr	-269Cr	-804Cr
Short Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Short Term Debt Repaid, Total	-33Cr	-35L	-	-	-
Long-Term Debt Repaid, Total	-74L	-79L	-43L	-1Cr	-1Cr
Total Debt Repaid	-34Cr	-1.14Cr	-43L	-1Cr	-1Cr
Common Dividends Paid	-	-530.94Cr	-796.41Cr	-796Cr	-796Cr
Common & Preferred Stock Dividends Paid	-	-530.94Cr	-796.41Cr	-796Cr	-796Cr
Other Financing Activities, Total	-87L	-36L	-33L	-2Cr	-2Cr
Cash from Financing	-35Cr	-532.44Cr	-797.17Cr	-799Cr	-799Cr
Net Change in Cash	1.99TCr	-815.56Cr	-1.05TCr	193Cr	50Cr
Supplemental Items
Cash Interest Paid	39L	37L	66L	3Cr	2Cr
Cash Income Tax Paid (Refund)	644.32Cr	640.98Cr	472.65Cr	376Cr	824Cr
Levered Free Cash Flow	762.82Cr	398.4Cr	1.47TCr	-103.5Cr	165Cr
Unlevered Free Cash Flow	763.06Cr	398.63Cr	1.47TCr	-101.62Cr	166.25Cr
Change In Net Working Capital	216.56Cr	1.43TCr	-336.32Cr	621Cr	404Cr
Net Debt Issued / Repaid	-34Cr	-1.14Cr	-43L	-1Cr	-1Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	16.93	18.49	9.1	7.65	9.91
Return on Total Capital	19.63	21.23	10.34	8.69	11.25
Return On Equity %	23.9	28.16	14.89	12.15	15.35
Return on Common Equity	23.9	28.16	14.89	12.15	15.35
Margin Analysis
Gross Profit Margin %	64.46	64.66	57.81	57.27	60.2
SG&A Margin	12	10.68	12.71	14.1	13.44
EBITDA Margin %	41.13	43.3	30.44	28.11	31.71
EBITA Margin %	37.52	39.87	26.08	23.34	27.46
EBIT Margin %	37.52	39.87	26.08	23.34	27.46
Income From Continuing Operations Margin %	28.47	33.04	23.47	20.4	23.41
Net Income Margin %	28.47	33.04	23.47	20.4	23.41
Net Avail. For Common Margin %	28.47	33.04	23.47	20.4	23.41
Normalized Net Income Margin	23.94	25.71	19.07	17.22	19.46
Levered Free Cash Flow Margin	10.95	4.45	18.96	-1.32	1.76
Unlevered Free Cash Flow Margin	10.95	4.45	18.96	-1.3	1.78
Asset Turnover
Asset Turnover	0.72	0.74	0.56	0.52	0.58
Fixed Assets Turnover	1.72	1.95	1.6	1.5	1.56
Receivables Turnover (Average Receivables)	4.51	4.37	3.68	3.97	3.83
Inventory Turnover (Average Inventory)	1.24	1.27	1.12	1.08	1.16
Short Term Liquidity
Current Ratio	5.55	6.99	8.46	7.57	6.94
Quick Ratio	3.47	4.41	5.51	4.74	4.48
Operating Cash Flow to Current Liabilities	1.75	1.6	2.23	0.99	1.14
Days Sales Outstanding (Average Receivables)	80.91	83.52	99.07	92.12	95.29
Days Outstanding Inventory (Average Inventory)	295.37	286.7	324.61	337.61	314.54
Average Days Payable Outstanding	89.58	73.9	82.45	82.08	83.78
Cash Conversion Cycle (Average Days)	286.7	296.31	341.22	347.65	326.04
Long Term Solvency
Total Debt/Equity	0.05	0.03	0.03	0.02	0.03
Total Debt / Total Capital	0.05	0.03	0.03	0.02	0.03
LT Debt/Equity	0.04	0.02	0.02	0.01	0.01
Long-Term Debt / Total Capital	0.04	0.02	0.02	0.01	0.01
Total Liabilities / Total Assets	13.73	12.31	11.58	12.28	11.59
EBIT / Interest Expense	6.7T	9.66T	6.14T	610.33	1.28T
EBITDA / Interest Expense	7.35T	10.49T	7.17T	735.33	1.48T
(EBITDA - Capex) / Interest Expense	5.02T	8.56T	5.73T	401	765.5
Total Debt / EBITDA	0	0	0	0	0
Net Debt / EBITDA	-0.73	-0.71	-1.75	-1.67	-1.19
Total Debt / (EBITDA - Capex)	0	0	0	0	0
Net Debt / (EBITDA - Capex)	-1.06	-0.86	-2.18	-3.07	-2.3
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	29.2	28.56	-13.31	1	19.31
Gross Profit, 1 Yr. Growth %	42.86	28.97	-22.5	0	25.42
EBITDA, 1 Yr. Growth %	57.3	35.36	-39.07	-6.73	34.6
EBITA, 1 Yr. Growth %	59.51	36.63	-43.29	-9.62	40.36
EBIT, 1 Yr. Growth %	59.51	36.63	-43.29	-9.62	40.36
Earnings From Cont. Operations, 1 Yr. Growth %	44.15	49.19	-38.41	-12.28	36.94
Net Income, 1 Yr. Growth %	44.15	49.19	-38.41	-12.28	36.94
Normalized Net Income, 1 Yr. Growth %	51.38	38.07	-35.7	-8.58	34.83
Diluted EPS Before Extra, 1 Yr. Growth %	44.16	49.19	-38.41	-12.26	36.93
Accounts Receivable, 1 Yr. Growth %	18.62	44.58	-26.05	20.25	26.67
Inventory, 1 Yr. Growth %	15.1	31.86	6.07	6.13	1.63
Net Property, Plant and Equip., 1 Yr. Growth %	19.24	8.57	2.96	11.85	17.18
Total Assets, 1 Yr. Growth %	26.22	24.14	7.96	7.14	9.45
Tangible Book Value, 1 Yr. Growth %	27.15	26.17	8.88	6.31	10.3
Common Equity, 1 Yr. Growth %	27.15	26.18	8.86	6.3	10.3
Cash From Operations, 1 Yr. Growth %	60.12	-1.8	28.66	-48.72	31.09
Capital Expenditures, 1 Yr. Growth %	-23.07	-21.64	-33.68	112.05	43.37
Levered Free Cash Flow, 1 Yr. Growth %	-417.55	-47.49	269.59	-107.03	-259.42
Unlevered Free Cash Flow, 1 Yr. Growth %	-422.29	-47.47	269.43	-106.9	-263.59
Dividend Per Share, 1 Yr. Growth %	25	50	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	18.7	28.88	5.57	-6.43	9.78
Gross Profit, 2 Yr. CAGR %	21.92	35.74	-0.02	-11.94	11.99
EBITDA, 2 Yr. CAGR %	23.65	45.91	-9.18	-24.62	12.05
EBITA, 2 Yr. CAGR %	23.71	47.63	-11.98	-28.41	12.63
EBIT, 2 Yr. CAGR %	23.71	47.63	-11.98	-28.41	12.63
Earnings From Cont. Operations, 2 Yr. CAGR %	21.11	46.65	-4.14	-26.48	9.6
Net Income, 2 Yr. CAGR %	21.11	46.65	-4.14	-26.48	9.6
Normalized Net Income, 2 Yr. CAGR %	20.8	44.57	-5.78	-23.41	11.02
Diluted EPS Before Extra, 2 Yr. CAGR %	21.11	46.66	-4.14	-26.48	9.61
Accounts Receivable, 2 Yr. CAGR %	20.05	30.96	3.4	-5.69	23.42
Inventory, 2 Yr. CAGR %	10.02	23.19	18.26	6.1	3.86
Net Property, Plant and Equip., 2 Yr. CAGR %	30.84	13.78	5.73	7.31	14.48
Total Assets, 2 Yr. CAGR %	15.77	25.18	15.76	7.55	8.29
Tangible Book Value, 2 Yr. CAGR %	15.59	26.66	17.21	7.59	8.29
Common Equity, 2 Yr. CAGR %	15.58	26.67	17.2	7.57	8.28
Cash From Operations, 2 Yr. CAGR %	42.83	25.39	12.4	-18.78	-18.01
Capital Expenditures, 2 Yr. CAGR %	11.43	-22.36	-27.91	18.59	74.36
Levered Free Cash Flow, 2 Yr. CAGR %	365.4	28.78	39.31	-49.03	-66.52
Unlevered Free Cash Flow, 2 Yr. CAGR %	356.96	29.76	39.3	-49.51	-66.4
Dividend Per Share, 2 Yr. CAGR %	11.8	36.93	22.47	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	21.44	21.9	12.92	4.02	1.47
Gross Profit, 3 Yr. CAGR %	25.56	24.23	12.61	0	-0.92
EBITDA, 3 Yr. CAGR %	31.25	27.44	9.06	-8.37	-8.54
EBITA, 3 Yr. CAGR %	32.35	27.87	7.31	-11.2	-10.4
EBIT, 3 Yr. CAGR %	32.35	27.87	7.31	-11.2	-10.4
Earnings From Cont. Operations, 3 Yr. CAGR %	31.28	29.83	9.82	-6.92	-9.55
Net Income, 3 Yr. CAGR %	31.28	29.83	9.82	-6.92	-9.55
Normalized Net Income, 3 Yr. CAGR %	29.3	26.3	10.35	-6.79	-7.52
Diluted EPS Before Extra, 3 Yr. CAGR %	31.28	29.83	9.83	-6.92	-9.55
Accounts Receivable, 3 Yr. CAGR %	18.23	27.72	8.24	8.75	4.06
Inventory, 3 Yr. CAGR %	16.67	16.86	17.2	14.07	4.59
Net Property, Plant and Equip., 3 Yr. CAGR %	27.86	22.95	10.05	7.73	10.5
Total Assets, 3 Yr. CAGR %	16.66	18.5	19.15	12.82	8.18
Tangible Book Value, 3 Yr. CAGR %	16.22	19.01	20.43	13.46	8.49
Common Equity, 3 Yr. CAGR %	16.19	19.01	20.43	13.45	8.47
Cash From Operations, 3 Yr. CAGR %	35.89	26.06	26.47	-13.48	-4.73
Capital Expenditures, 3 Yr. CAGR %	49.23	-0.91	-26.33	3.29	26.33
Levered Free Cash Flow, 3 Yr. CAGR %	39.99	124.48	83.01	-48.52	-25.46
Unlevered Free Cash Flow, 3 Yr. CAGR %	39.95	121.78	83.91	-48.84	-25.29
Dividend Per Share, 3 Yr. CAGR %	25.99	23.31	23.31	14.47	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	13.04	17.13	14.82	9.66	11.65
Gross Profit, 5 Yr. CAGR %	15.29	18.75	14.62	8.25	12.37
EBITDA, 5 Yr. CAGR %	15.05	21.14	13.27	3.3	10.25
EBITA, 5 Yr. CAGR %	14.9	21.2	12.43	1.39	9.41
EBIT, 5 Yr. CAGR %	14.9	21.2	12.43	1.39	9.41
Earnings From Cont. Operations, 5 Yr. CAGR %	12	22.79	15.76	3.41	9.74
Net Income, 5 Yr. CAGR %	12	22.79	15.76	3.41	9.74
Normalized Net Income, 5 Yr. CAGR %	13.83	21.47	13.92	3.4	10.58
Diluted EPS Before Extra, 5 Yr. CAGR %	12	22.79	15.76	3.41	9.74
Accounts Receivable, 5 Yr. CAGR %	13.74	21.89	12.06	13.13	14.08
Inventory, 5 Yr. CAGR %	12.17	16.47	17.31	12.43	11.67
Net Property, Plant and Equip., 5 Yr. CAGR %	21	19.08	18.5	16.44	11.8
Total Assets, 5 Yr. CAGR %	17.06	16.78	16.3	13.99	14.68
Tangible Book Value, 5 Yr. CAGR %	16.71	16.96	16.61	14.3	15.42
Common Equity, 5 Yr. CAGR %	16.7	16.96	16.6	14.3	15.41
Cash From Operations, 5 Yr. CAGR %	13.41	10.69	25.96	5.73	6.33
Capital Expenditures, 5 Yr. CAGR %	18.13	13.62	11.55	6.47	3.98
Levered Free Cash Flow, 5 Yr. CAGR %	88.14	-7.65	39.57	24.06	-7.24
Unlevered Free Cash Flow, 5 Yr. CAGR %	86.44	-7.66	39.54	22.7	-6.83
Dividend Per Share, 5 Yr. CAGR %	14.87	24.57	24.57	13.4	13.4